 |
A Grey MatterAuthor: Queensland Brain Institute
A Grey Matter is for anyone who has ever wondered how we think, feel, reason and move. The Queensland Brain Institute's neuroscience podcast unlocks the wonders of the brain the complex and mysterious core of who we are and what makes us human. QBI researchers, at The University of Queensland, strive to understand the development, organisation and function of the brain in health and disease. www.qbi.uq.edu.au Language: en Genres: Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Rethinking schizophrenia treatment
Episode 11
Tuesday, 19 May, 2026
Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects.At UQ, a neuroscientist, a chemist and a psychiatrist have hit on a formulation that may revolutionise the treatment of schizophrenia. The research team, led by Professor Darryl Eyles and Dr Xiaoying Cui, are investigating a new delivery mode for clozapine, in the hope that it may be better tolerated by people living with schizophrenia and improve their quality of life.In this engaging conversation, Darryl and Xiaoying discuss: Treatment-resistant schizophrenia and the side-effects of clozapineCollaborating with chemists to develop intranasal deliveryWhat they have found so far in preclinical studies The potential impact of their research on schizophrenia treatmentRelated resourcesIntranasal clozapine sol-gel formulation induces an antipsychotic effect at a fraction of a comparable oral therapeutic doseEpitranscriptomic regulation of striatal function: a new neurobiology of schizophreniaSchizophrenia research at QBI
